News Agency
Men's Weekly

Abbisko will debut two blockbuster clinical research results at the 2023 European Society for Medical Oncology(ESMO)

  • Written by PR Newswire

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) announced that the clinical results of first-in-human study of FGFR4 inhibitor Irpagratinib(ABSK011)and the clinical results of first-in-human dose-escalating of PD-L1 inhibitor ABSK043 with advanced...

Read more: Abbisko will debut two blockbuster clinical research results at the 2023 European Society for...

Defence Recruitment: Building Australia’s Future Security Workforce

Australia’s defence sector is one of the nation’s most vital and rapidly evolving industries, offering stable and rewarding careers for individuals committed to protecting national interests. With the growing need for advanced technologies, cybersecurity, and global defence partnerships, opportunities in defence... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion